ZOLMITRIPTAN SUN 2.5 mg, orodispersible tablet 12 tablets
Active ingredients: Zolmitriptan
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZOLMITRIPTAN SUN 2,5 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC papier polytéréphtalate (PET) de 12 comprimé(s)
- Marketing authorisation holder
- SUN PHARMA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64879479CIP74975046CIP133400949750467Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ZOLMITRIPTANcomprimé | 2,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.